A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia

Journal of Medical Virology

Volumn 78, Issue 12, 2006, Pages 1554-1559

  Ijaz, Samreen ^a,c   Khulan, Janchiv ^b   Bissett, Sara L ^a   Ferns, R Bridget ^a   Nymadawa, Pagbajabyn ^b   Tedder, Richard S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Ministry of Health   (Mongolia)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Anti HBs levels; Hepatitis B virus; Immunization

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ANTIBODY TITER; ARTICLE; HEPATITIS A; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; INFECTION PREVENTION; MONGOLIA; SEROLOGY; VIRUS MUTANT;

HEPATITIS A VIRUS; HEPATITIS B VIRUS;

EID: 33750548619     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20738     Document Type: Article

References (32)

1. Adiyajav V, Alima D, Nymadawa P. 1995. Results of vaccination of newborns against HBV in Mongolia. Mongolian Med Sci 2:33-38.
2. Altankhuu B. 1993. Clinical and laboratory features of acute viral hepatitis with parenteral mechanisms of transmission in Mongolia. PhD thesis, Moscow.
3. Colombari R, Dhillon AP, Piazzola E, Tomezzoli AA, Angelini GP, Capra F, Tomba A, Scheuer PJ. 1993. Chronic hepatitis in multiple virus infection: Histopathological evaluation. Histopathology 22:319-325.
4. Dawaasuren D. 2001. Epidemiology and some clinical peculiarities of viral hepatitis B, C and D among children of Ulaanbaatar City, Mongolia. PhD thesis, Ulaanbaatar.
5. Edstam JS, Dulmaa N, Nymadawa P, Rinchin A, Khulan J, Kimball AM. 2002. Comparison of hepatitits B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-olds. Prev Med 34:207-214.
6. Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, Schalm SW. 2000. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. Gut 46:420-426.
7. Francois G, Kew M, Van Damme P, Mphahlele MJ, Meheus A. 2001. Mutant hepatitis B viruses: A matter of academic interest only or a problem with far-reaching implications? Vaccine 19:3799-3815.
8. Hsu HY, Chang MH, Liaw AH, Ni YH, Chen HL. 1999. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 30:1312-1317.
9. Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC. 1999. What level of hepatitis B antibody is protective? J Infect Dis 179:489-492.
10. Keeffe EB. 1995. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol 90:201-205.
11. Lefilliatre P, Villeneuve JP. 2000. Fulminant hepatitis A in patients with chronic liver disease. Can J Public Health 91:168-170.
12. Lin DB, Wang HM, Lee YL, Ling UP, Changlai SP, Chen CJ. 1998. Immune status in preschool children born after mass hepatitis B vaccination program in Taiwan. Vaccine 16:1683-1687.
13. Ministry of Health, Mongolia. 2002. Health sector of Mongolia, 80 years, 2nd revised edition.
14. Ministry of Health, Mongolia. 2004. Health Indicators 2003. Ulaanbaatar: ADMON Press; 38-39.
15. Nainan OV, Khristova ML, Byun K, Xia G, Taylor PE, Stevens CE, Margolis HS. 2002. Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection. J Med Virol 68:319-327.
16. Nymadawa P. 1989. Correlation between morbidity of viral infections and population immunity to viruses in Mongolia. DSc(Med) thesis, Moscow.
17. Nymadawa P. 2004. Hepatitis B vaccination worldwide and in Mongolia. In: The Tenth National Conference 'Current Topics of Virology' (Abstracts pp 115-116).
18. Oon CJ, Lim GK, Ye Z, Goh KT, Tan KL, Yo SL, Hopes E, Harrison TJ, Zuckerman AJ. 1995. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 13:699-702.
19. Oon CJ, Tan KL, Harrison T, Zuckerman A. 1996. Natural history of hepatitis B surface antigen mutants in children. Lancet 348:1524.
20. Rizzetto M, Canese MG, Arico S, Crivelli O, Trepo C, Bonino F, Verme G. 1997. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 18:997-1003.
21. Takahashi M, Nishizawa T, Gotanda Y, Tsuda F, Komatsu F, Kawabata T, Hasegawa K, Altankhuu M, Chimedregzen U, Narantuya L, Hoshino H, Hino K, Kagawa Y, Okamoto H. 2004. High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C and D viruses among apparently healthy populations in Mongolia. Clin Diag Lab Immunol 11:392-398.
22. Tedder RS, Cameron CH, Wilson-Croome R, Howell DR, Colgrove A, Barbara JA. 1981. Contrasting patterns and frequency of antibodies to the surface, core, and e antigens of hepatitis B virus in blood donors and in homosexual patients. J Med Virol 6:323-332.
23. Tedder RS, Briggs M, Howell DR. 1982. UK prevalence of delta infection. Lancet 2:764-765.
24. Tedder RS, Zuckerman MA, Brink N. 1993. Hepatitis B vaccination: Non-repsondes must be detected. Lancet 307:732.
25. Tsen YJ, Chang MH, Hsu HY, Lee CY, Sung JL, Chen DS. 1991. Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: Five years after a mass hepatitis B vaccination program. J Med Virol 34:96-99.
26. Viviani S, Jack A, Hall AJ, Maine N, Mendy M, Montesano R, Whittle HC. 1999. Hepatitis B vaccination in infancy in The Gambia: Protection against carriage at 9 years of age. Vaccine 17:2946-2950.
27. Weltman MD, Brotodiharadjo A, Crewe EB, Farrell GC, Bilous M, Grierson JM, Liddle C. 1995. Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment. J Viral Hepat 2:39-45.
28. Whittle HC, Inskip H, Hall AJ, Mendy M, Downes R, Hoare S. 1991. Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia. Lancet 337:747-750.
29. Whittle HC, Maine N, Pilkington J, Mendy M, Firtuin M, Bunn J, Allison L, Howard C, Hall A. 1995. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. Lancet 345:1089-1092.
30. WHO, UNICEF, WB. 2002. State of the World's vaccines and immunization. Geneva, 43.
31. Xu DZ, Yan YP, Choi BCK, Xu JQ, Men K, Zhang JX, Liu ZH, Wang FS. 2002. Risk factors and mechanisms of transplacental transmission of hepatitis B virus: A case-control study. J Med Virol 67:20-26.
32. Zuckerman JN. 1996. Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production. J Med Virol 50:283-288.